Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Doors locked and ready to be sold off perhaps !

<< Previous

Bullboard Posts

Next >>

Comment by SamV21on Jul 08, 2023 1:03pm

384 Views

Post# 35532173

RE:Doors locked and ready to be sold off perhaps !

Nothing on Health Canada site for famous Reduvo do over any more , so many side effects it was pulled off the market years ago and nothing close to being baked in the Tetra cook book besides shareholders , 4 weeks , 4 years another connection made with another going no where company in hopes of a life line , battery died in my analog phone since Guy told us to wait by the phone for news. white collar crime at its finest .The only pipeline Tetra has leads to the sewage lagoon.

<< Previous

Bullboard Posts

Next >>

The investment impact of the U.S. 25% tariff on Canadian imports